Recent Articles


How High Can Healthcare Go?

Tickers: XLV, IBB, HSP

Healthcare has been a top performing sector for the past few years, gaining more in Tuesday’s session so MoneyShow’s Tom Aspray


These Funds Keep the Faith

Having faith in your investments takes on a new meaning with this sector of mutual funds; Carolyn Bigda of Kiplinger’s Personal…


Low Risk, High Yield Trio

Tickers: VZ, LMT, INTC

Loss prevention is often an overlooked concept in investing. Too often, investors are worried about potential returns, observes Marshall…


Stick with Bristol-Myers

Tickers: BMY

With solid earnings, strong balance sheets, share buybacks, above-market dividend yields, and an emerging growth element we continue to recommend…


VIX Is Really Expensive

Tickers: VIX

Mark Sebastian of shares his theory as to why the VIX hasn’t been absolutely destroyed by the market this week and…


Gilead: A Biotech Buy

Tickers: GILD

Our latest recommendation is a biotech giant well known for its success with HIV drugs and, lately, its hepatitis drug, Sovaldi, explains Nicholas…


End of the Iron Age?

Tickers: BHP, RIO, VALE

The recent forecast for iron ore prices from Goldman Sachs, says MoneyShow’s Jim Jubak, could have long-term implications for…